載入...
Tetracyclines increase the survival of NSCLC patients treated with EGFR TKIs: a retrospective nationwide registry study
BACKGROUND: With the first and second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), clinical benefit and rash correlate together. EGFR TKI-induced rash can be alleviated with tetracyclines, but it is unknown whether the use of tetracyclines can increase the su...
Na minha lista:
| 發表在: | ESMO Open |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7580060/ https://ncbi.nlm.nih.gov/pubmed/33087401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000864 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|